FDA inspection
Pillar5 Pharma Inc.: FDA inspection ending Feb 7, 2025
FDA inspection 1261773 · Voluntary Action Indicated (VAI) · Arnprior
Key facts
| Inspection ID | 1261773 |
|---|---|
| Firm | Pillar5 Pharma Inc. |
| FEI number | 3000241849 |
| Address | 365 Madawaska Blvd, |
| City | Arnprior |
| Country | Canada |
| Fiscal year | 2025 |
| Inspection end date | Feb 7, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data